Australia - English - Department of Health (Therapeutic Goods Administration)

haleon australia pty ltd - nicotine, quantity: 114 mg (equivalent: nicotine, qty 21 mg/24 h) - drug delivery system, transdermal - excipient ingredients: polyethylene; ethylene dioleamide; ethylene/vinyl acetate copolymer; polyisobutylene; titanium dioxide; ethyl acetate; ethanol; isopropyl alcohol; methoxyisopropanol; ethylcellulose; pyroxylin - for the treatment of nicotine dependence as an aid to smoking cessation.

Australia - English - Department of Health (Therapeutic Goods Administration)

haleon australia pty ltd - nicotine, quantity: 78 mg (equivalent: nicotine, qty 14 mg/24 h) - drug delivery system, transdermal - excipient ingredients: ethylene dioleamide; polyethylene; ethylene/vinyl acetate copolymer; polyisobutylene; titanium dioxide; ethyl acetate; ethanol; isopropyl alcohol; methoxyisopropanol; ethylcellulose; pyroxylin - for the treatment of nicotine dependence as an aid to smoking cessation.

Australia - English - Department of Health (Therapeutic Goods Administration)

haleon australia pty ltd - nicotine, quantity: 36 mg (equivalent: nicotine, qty 7 mg/24 h) - drug delivery system, transdermal - excipient ingredients: ethylene dioleamide; polyisobutylene; ethylene/vinyl acetate copolymer; polyethylene; titanium dioxide; ethyl acetate; ethanol; isopropyl alcohol; methoxyisopropanol; ethylcellulose; pyroxylin - for the treatment of nicotine dependence as an aid to smoking cessation.

Australia - English - Department of Health (Therapeutic Goods Administration)

nutri health foods centre pty ltd - citrus aurantium, quantity: 14 mg/g (equivalent: citrus aurantium, qty 140 mg/g; equivalent: oxedrine, qty 3 mg/g); hordeum vulgare, quantity: 8 mg/g (equivalent: hordeum vulgare, qty 80 mg/g); crataegus pinnatifida, quantity: 12 mg/g (equivalent: crataegus pinnatifida, qty 120 mg/g); alisma orientale, quantity: 8 mg/g (equivalent: alisma orientale, qty 80 mg/g); nelumbo nucifera, quantity: 14 mg/g (equivalent: nelumbo nucifera, qty 140 mg/g); senna alexandrina, quantity: 920 mg/g (equivalent: senna alexandrina, qty 920 mg/g; equivalent: hydroxyanthracene glycosides calculated as sennoside b, qty 25 mg/g); plantago asiatica, quantity: 12 mg/g (equivalent: plantago asiatica, qty 120 mg/g); senna tora, quantity: 12 mg/g (equivalent: senna tora, qty 120 mg/g; equivalent: hydroxyanthracene glycosides calculated as sennoside b, qty 0.25 mg/g) - herb, dried - excipient ingredients: - traditionally used in western herbal medicine to aids/assists natural body cleansing/detoxification processes ; traditionally used in western herbal medicine to maintain/support natural body cleansing/detoxification processes ; traditionally used in western herbal medicine to aids/assists natural cleansing/detoxification processes of the gastrointestinal system/gut ; traditionally used in western herbal medicine to decrease/reduce/relieve constipation ; decrease/reduce/relieve constipation ; traditionally used in western herbal medicine to aperient/laxative ; aperient/laxative

Australia - English - Department of Health (Therapeutic Goods Administration)

health spring australia - beta vulgaris, quantity: 22.22 mg/g; ascorbic acid, quantity: 2.67 mg/g; psyllium husk powder, quantity: 411.1 mg/g; zingiber officinale, quantity: 6.67 mg/g (equivalent: zingiber officinale, qty 73.37 mg/g); vitis vinifera, quantity: 6.67 mg/g (equivalent: vitis vinifera, qty 800.4 mg/g); fructooligosaccharides, quantity: 55.56 mg/g; inulin, quantity: 33.33 mg/g; levocarnitine tartrate, quantity: 55.56 mg/g; malpighia glabra, quantity: 6.67 mg/g (equivalent: malpighia glabra, qty 33.35 mg/g); vaccinium macrocarpon, quantity: 2 mg/g (equivalent: vaccinium macrocarpon, qty 1000 mg/g); citrus sinensis, quantity: 2 mg/g (equivalent: citrus sinensis, qty 60 mg/g; equivalent: oxedrine, qty 0.1 microgram/g); prunus domestica, quantity: 33.33 mg/g (equivalent: amygdalin, qty 0 mg/g; equivalent: hydrocyanic acid, qty 0 mg/g); punica granatum, quantity: 2.67 mg/g (equivalent: punica granatum, qty 267 mg/g); senna alexandrina, quantity: 33.33 mg/g (equivalent: senna alexandrina, qty 333.3 mg/g; equivalent: hydroxyanthracene glycosides calculated as sennoside b, qty 7 mg/g) - powder - excipient ingredients: colloidal anhydrous silica; maltodextrin; polydextrose; pectin; malic acid; thaumatin; citric acid; flavour - antioxidant/reduce free radicals formed in the body ; aids/assists natural body cleansing/detoxification processes ; maintain/support natural body cleansing/detoxification processes ; helps enhance/promote general health and wellbeing ; maintain/support general health and wellbeing ; enhance/improve/promote/increase bowel waste elimination ; helps enhance/improve/promote/increase healthy digestive system flora/good bacteria growth

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - granisetron hydrochloride, quantity: 3.36 mg (equivalent: granisetron, qty 3 mg) - injection, concentrated - excipient ingredients: water for injections; sodium chloride; nitrogen; citric acid monohydrate; sodium citrate dihydrate - granisetron injection is indicated in:,adults: - for the prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy - for the prevention of nausea and vomiting induced by radiotherapy,children: - for the prevention of nausea and vomiting induced by cytotoxic chemotherapy

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - granisetron hydrochloride, quantity: 1.12 mg (equivalent: granisetron, qty 1 mg) - injection, concentrated - excipient ingredients: water for injections; sodium chloride; nitrogen; sodium citrate dihydrate; citric acid monohydrate - granisetron injection is indicated in:,adults: - for the prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy - for the prevention of nausea and vomiting induced by radiotherapy,children: - for the prevention of nausea and vomiting induced by cytotoxic chemotherapy

United States - English - NLM (National Library of Medicine)

allure labs, inc. - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - i ndications and usage section: a salicylic/glycolic acid skin pad to effectively remove impurities and excess oil. deeply clears clogged pores and follicles to leave skin fresh and clean. a blend of anti-oxidants and calming ingredients reduce acneic inlfammation. excellent for on the road cleaning and after physical activities. paraben free effective home care exfoliation directions: take out one pad at a time and apply by gently rubbing on entire face or affected areas. use a broad spectrum sunscreen like the sun solar defense oil free after usage.

United States - English - NLM (National Library of Medicine)

allure labs, inc. - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - indications and usage section: a daily salicylic acid cleanser that exfoiates, gently removes makeup and diminishes excess oil. anti-oxidants keep skin soft, purified and shine-free. paraben free directions: apply to wet face and massage for 1 minute. repeat cleansing for additional exfoliation. indications: acne and acne-prone skin

United States - English - NLM (National Library of Medicine)

aquimpex spa - active ingredients: hydroquinone 2.00% - dermofading cream face clear maxi tone 5+ specially designed to impart youthful glow and supreme brightness to dull skin with uneven tone. its action enhances skin luminosity in as little as few weeks. use: spread a thin layer on skin areas to be treated; apply mornings and evenings on perfectly cleansed skin, massaging delicately until complete absorption. use: spread a thin layer on skin areas to be treated; apply mornings and evenings on perfectly cleansed skin, massaging delicately until complete absorption.